Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The DISCUSS Project: Induced Pluripotent Stem Cell Lines From Previously Collected Research Biospecimens and Informed Consent: Points to Consider

29 Aug 2013

Abstract excerpt

Human somatic cell reprogramming is a leading technology for accelerating disease modeling and drug discovery. Research organizations are sponsoring initiatives to create libraries of induced pluripotent stem cell (iPSC) lines for broad distribution and application. Donor informed consent plays a critical role in supporting the ethical conduct of iPSC research. To date, our organizations have focused on informed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23990574
DOI: 10.5966/sctm.2013-0099

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The DISCUSS Project: Induced Pluripotent Stem Cell Lines From Previously Collected Research Biospecimens and Informed Consent: Points to ConsiderPMID 23990574Read ↗

Obtaining Consent for Future Research with Induced Pluripotent Cells: Opportunities and ChallengesSemantic proximity Read ↗

A practical guide to induced pluripotent stem cell research using patient samplesSemantic proximity Read ↗

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical ApplicationSemantic proximity Read ↗

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical ApplicationsSemantic proximity Read ↗

Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerationsSemantic proximity Read ↗

Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell LinesSemantic proximity Read ↗

The EBiSC iPSC bank for disease studiesSemantic proximity Read ↗

Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research PurposesSemantic proximity Read ↗

Access to stem cell data and registration of pluripotent cell lines: The Human Pluripotent Stem Cell Registry (hPSCreg)Semantic proximity Read ↗

Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical TrialsSemantic proximity Read ↗

Points to Consider in the Development of Seed Stocks of Pluripotent Stem Cells for Clinical Applications: International Stem Cell Banking Initiative (ISCBI)Semantic proximity Read ↗

A Manually Curated Database on Clinical Studies Involving Cell Products Derived from Human Pluripotent Stem CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.